10-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-K/A

Amendment No. 3

oANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008

Or

oTRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER     333-136436

DIAGNOSTIC IMAGING INTERNATIONAL CORP.

(Exact name of registrant as specified in charter)

NEVADA	98-0493698
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

848 N. Rainbow Blvd. #2494, Las Vegas, Nevada	89107
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code: (603)-727-8613

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  

o

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

x

(Do not check if smaller reporting company)

Indicate by check mark whether the registrant is a shell company as defined in Rule 126-2 of the Exchange Act.   Yes o No x

State the aggregate market value of the voting stock held by non-affiliates computed by reference to the price at which the stock was sold, or the average big and asked prices of such stock as of a specified date within the past 60 days; As of March 26, 2009, the aggregate market price of the voting stock held by non-affiliates was approximately $923,140.

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: As of March 26, 2009, the Company had outstanding 13,154,266 shares of its common stock, par value $0.001.

TABLE OF CONTENTS

ITEM NUMBER AND CAPTION		PAGE
PART I
ITEM 1.	BUSINESS	3
ITEM 2.	PROPERTY	17
ITEM 3.	LEGAL PROCEEDINGS	17
ITEM 4.	SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS	17
PART II
ITEM 5.	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY	18
ITEM 6.	SELECTED FINANCIAL DATA	20
ITEM 7.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	20
ITEM 8.	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA      Consolidated Balance Sheets – December 31, 2008 and December 31, 2007      Consolidated Statements of Expenses – Years Ended December 31, 2008 and 2007 and from inception      Consolidated Statement of Changes in Stockholders’ Deficit – Years Ended December 31, 2008 and      2007 and from inception      Consolidated Statements of Cash Flows – Years Ended December 31, 2008 and 2007 and from inception	26
ITEM 9.	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	36
ITEM 9A.	CONTROLS AND PROCEDURES	36
ITEM 9B.	OTHER ITEMS	38
PART III
ITEM 10.	DIRECTORS, EXECUTIVE OFFICERSAND CORPORATE GOVERNANCE	39
ITEM 11.	EXECUTIVE COMPENSATION	42
ITEM 12.	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	43
ITEM 13.	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE	43
ITEM 14.	PRINCIPAL ACCOUNTANT FEES AND SERVICES	43
PART IV
ITEM 15.	EXHIBITS, FINANCIAL STATEMENT SCHEDULES	44
SIGNATURES		45

2

PART I

ITEM 1. DESCRIPTION OF BUSINESS

COMPANY HISTORY

Diagnostic Imaging International Corp., a Nevada Corporation, was incorporated on December 12, 2000. Prior to August 19, 2005, the Company was named Galloway Investments Corp. Galloway Investment Corp. was originally established to make investments in real estate properties with development or improvement potential.  One market in which this business plan was going to be pursued was in Canada and for that reason, upon inception, Galloway Investments Corp. created a subsidiary called Galloway Properties Corp.  The real estate market in both the United States and Canada, however, became very active and prices increased rapidly in the 2001-2004 time period.  The then management did not believe there were properties with the characteristics it sought and sufficient upside value to be found.  Therefore, the Company did not pursue any acquisitions of real estate.  In its pursuit of its real estate business objectives, management observe d a certain amount of leasing activity in Canada in connection with private medical facilities, and management came to believe that there was a potential for growth of independent medical clinics in Canada.  In July 2005, the Company engaged Mr. Richard Jagodnik to advise it on private healthcare opportunities in Canada and, if there was sufficient opportunity, to develop a new business plan with the objective of owning and operating private diagnostic clinics.  In August 2005, Galloway Properties Corp. was effectively dissolved.

BUSINESS

Proposed Operations

Diagnostic Imaging is a development-stage company. We currently do not offer any products or services.

Our proposed business plan is to open and/or acquire and operate diagnostic imaging clinics in Canada. Our primary plan will focus on Magnetic Resonance Imaging (“MRI”) clinics. If we are successful in the implementation of the MRI clinics, we anticipate adding Computed Tomography (“CT”) scan equipment to those facilities and also will examine future opportunities for Positron Emission Tomography (“PET”) clinics. We intend to provide imaging services for fees to private individuals, workers compensation boards, private insurance companies and those not covered by government insured programs.

We believe that the future for private MRI clinics in Canada is positive. The present public delivery model is not meeting the requirements of all Canadians. Waiting lists are long and there is widespread public dissatisfaction with the current services provided. According to the Future of Health Care in Canada – Final Report dated November 2002, studies and public opinion polls have consistently shown that one of the top concerns of rural and urban Canadians is health care access. At their August 2002 meeting, Canada’s Premier’s acknowledged that access to health services was the highest priority for all Canadian citizens. Time and time again, the Commission heard that when it comes to access to specific diagnostic procedures and surgical procedures, wait lists (i.e. the number of people waiting for a particular service) and waiting times (i.e. the average time people are on the wait list before they receive service) are too long. Long wai t times are the main, and in many cases, the only reason some Canadians say they would be willing to pay for treatments outside of the public health care system.

In addition, The Conference Board of Canada issued a report in February 2006, “Healthy Provinces, Healthy Canadians – A Provincial Benchmarking Report indicating that a 2005 Commonwealth Fund International Health Policy Survey showed that Canadians are dissatisfied with the overall state of their health care system, with 78% indicating that the system needs to be fundamentally changed or completely rebuilt.

Based on existing MRI clinics per population and provincial restrictions, we believe that Vancouver, British Columbia and Winnipeg, Manitoba are the best locations for the start-up of our diagnostic imaging clinics. If we are successful with those operations we intend to open a third clinic in Montreal, Quebec

3

We conducted research to determine the locations of current private MRI clinics operating in Canada. Our findings are included in the table below:

Location	Population	Number of MRI Clinics	Population per Clinic
Montreal, Quebec	3,635,700	12	302,975
Vancouver and Lower Mainland, British Columbia	2,208,100	6	368,017
Hull & Gatineau, Quebec	1,148,800	3	382,933
Calgary, Alberta	1,068,300	5	212,060
Edmonton, Alberta	1,016,000	2	508,000
Quebec City, Quebec	717,600	1	358,800
Winnipeg, Manitoba	706,900	1	706,900
Halifax, Nova Scotia	380,800	1	380,800
Victoria, British Columbia	334,700	1	334,700
Saskatoon, Saskatchewan	235,800	1	235,800
Kelowna, British Columbia	162,555	1	162,555

Source – Statistics Canada – Canadian Census 2005

Our observations indicated that based on the city of Calgary, it was possible to operate clinics with a per clinic population of just over 212,000 people. However, we believe that wherever we could locate a clinic with a population of close to or at 300,000 would be preferred.

Based on the current population per existing private clinic, we believed that Vancouver, Winnipeg and Montreal could support additional clinics. While we have limited access to utilization rates, we did take into account this factor in our initial location selection.  We observed facility closure, open house, and had discussions with equipment vendors.

If we are successful in opening a clinic in each of our chosen locations the population per clinic would be as follows:

·

An additional clinic in Vancouver would equate to 315,000 people per clinic.

·

An additional clinic in Winnipeg would equate to 353,000 people per clinic.

·

An additional clinic in Montreal would equate to 280,000 people per clinic.

We believe the keys to success in the diagnostic imaging industry are providing quick access to services, competitive prices, patient-friendly environments and establishing good working relationships with area physicians and family doctors.

Diagnostic Imaging Technology

Diagnostic imaging services are noninvasive procedures that generate representations of the internal anatomy and convert them to film or digital media. Diagnostic imaging systems facilitate the early diagnosis of diseases and disorders, often minimizing the cost and amount of care required and reducing the need for costly and invasive diagnostic procedures.

MRI Technology

Magnetic Resonance Imaging is an investigative procedure to detect structural or anatomical problems inside the body without the need for exploratory surgery or more complex invasive tests. MRI scanning is a painless way to “see” through bones.

4

It can be used to detect problems in almost any area – head, brain, eyes, ears, neck, chest, abdomen, pelvis, spine and limbs. It is particularly useful for detecting nerve root compression (pinched, trapped nerves) in the spine by a slipped disc and is also commonly used to assess major joints (knees and ankles – torn ligaments, meniscus injuries).

During a Magnetic Resonance Imaging scan, radio waves are directed at protons, the nuclei of hydrogen atoms, in a strong magnetic field. The protons are first “excited” and then “relaxed” emitting radio signals, which can be computer processed to form three dimensional computerized sectional images of various parts of the body. Unlike other imaging methods, MRI does not use X-rays and has no known side effects.

In the body, protons are most abundant in the hydrogen atoms of water, so that an MRI image shows the differences in the water content and the distribution in various body tissues. Even different types of tissues within the same organ can be easily distinguished, such as the grey and white matter of the brain.

MRI has found wide applications in many branches of medicine. Neurology, cardiology, orthopedics, urology and general surgery all use MRI for making and confirming diagnosis. MRI can also be used in angiography studies without the need for contrast. MRI scans produce detailed pictures of soft body tissue and organs without using ionizing radiation, making early detection of cancers, neurological and musculoskeletal diseases possible.

An MRI machine contains a very large super conducting magnet; a radio-wave transmitter and a computer that together construct detailed pictures of parts of the body. This procedure is considered more accurate than anything else available including the CT scan. Images from MRI are often superior to those from CT scanning, particularly for soft tissues, brain, spinal cord, joints and the abdomen and in certain conditions such as Multiple Sclerosis. Using special techniques, MRI can also be used to visualize the blood vessels in isolation.”

Simple scans that do not require an injection can be done by a technician without a physician present. Scans that require a contrast agent (e.g. bowels, etc.) must be administered by a physician.

CT Technology

Also known as CAT scan or Computerized Axial Tomography, patients find this type of scan less claustrophobic than an MRI scan as the tunnel on a CT machine is much shorter than the tunnel on an MRI scanner.

Computed Tomography scans are a three dimensional “window” into the body through which doctors can see brain, spine, joint and internal organs. A CT scan consists of a highly sensitive X-ray beam that is focused on a special plane of the body. As this beam passes through the body, it is picked up by a detector, which feeds the information it receives into a computer. The computer analyzes the information on the basis of tissue density.

CT scans are preferred where bone details are of paramount importance (long bones, spine, skull) whereas the MRI produces much better soft tissue detail (brain, spinal cord, etc).

PET Technology

Positron Emission Tomography is a diagnostic examination that involves collecting images based on the delivery of radiation from the emission of positrons. Positrons are tiny particles emitted from a radioactive substance administered to the patient. The subsequent images of the body are used to evaluate a variety of diseases.

PET scans are most often used to detect cancer and to examine the effects of cancer therapy by characterizing biochemical changes in the cancer. These scans can be performed on the whole body. Patients with lung cancer, colon cancer, cancers in the head and neck, advanced breast cancer, lymphoma and melanoma can avoid some surgeries and invasive tests by having PET scans.

5

PET scans on the heart can be used to determine blood flow to the heart muscle and help evaluate signs of coronary artery disease. PET scans allow differentiation of nonfunctioning heart muscle from heart muscle that would benefit from a procedure, such as angioplasty or coronary artery bypass surgery. PET scans of the brain are used to evaluate patients who have memory disorders of undetermined causes, suspected or proven brain tumors or seizure disorders that are not responsive to medical therapy and are therefore candidates for surgery.

Revenue Sources and Pricing

We anticipate that we will receive revenues in the form of fees for services we render in providing MRI, CT and PET scans if we are successful in developing our business plan.  We may also be able to develop other ancillary services for which we would charge services fees.  It is anticipated that our services will be provided to private individuals, workers compensation boards, private insurance companies and persons not covered by government insurance programs.

We have conducted our own survey of clinics throughout Canada and developed an informal body of data about the current prices for similar services provided by private clinics.  Based solely on this internally developed data, we believe that MRI scan prices range from $535 to $725 depending on the area of the person that is scanned.  MRI scans that require contrast are typically an additional $200 because they involve a physician’s services and contrasting agents.  For example, we believe that CT scans cost an average of approximately $690 for a heart scan and $2,100 for a full body scan and virtual colonoscopy.  Based solely on this data, we believe that a PET scan costs approximately $1,900.

We anticipate that we will offer our services at prices comparable to the average prices stated above.  Notwithstanding our goal to provide competitive pricing, the prices of our services will be affected by our costs of operations which will depend on the locations in which we operate, the cost of equipment and leases, the compensation that we will have to pay our technicians, doctors and other service personnel and the reimbursement rates of third party payers.  Additionally, we cannot now determine the rates until we have operations in place and licensed, and we commence operations.  Since there is a significant amount of time required to obtain facility space and perform necessary renovations, acquisition of equipment, hiring and training and licensing, current pricing models may not be an accurate gauge of future prices necessary to operate a facility profitably.

We believe there is likely to be substantial growth of this percentage for the private sector in the coming years.  This means that there will be increased demand for such services and a ready market, but there will be increasing competition.  As the market expands, service pricing may have to be adjusted from time to time, which may affect margins and profits of a clinic.

We currently do not have adequate cash on hand to fund our planned business strategy discussed above and there can be no assurance we will achieve the necessary funding to move forward.

Canadian Healthcare Environment

The Canadian Healthcare System

The Canadian healthcare system is a government sponsored system that began in 1957, when Parliament approved the Hospital Insurance and Diagnostics Services Act. The Act provided free acute hospital care, laboratory and radiological diagnostic services to Canadians. By 1961, agreements were in place with all of the provinces and 99% of Canadians had free access to the health care services covered by the legislation.

It was followed by the Medical Care Act of 1966 that provided free access to physician services. By 1972, each province had established its own system of free access to physician services. The federal government shared in the funding.

6

The Canada Health Act

In 1984, the Government of Canada passed the Canada Health Act (CHA). The Canada Health Act created a publicly administered health care system that is comprehensive, universal and accessible. All medically necessary procedures are provided free of charge. The system provides diagnostic, treatment and preventive services regardless of income level or station in life. Access to care is not based on health status or ability to pay. Coverage is portable between provinces and territories.

Canada’s healthcare system, otherwise known as Medicare, is a single insurance pay system. This means that any Canadian resident can receive medically necessary services from a doctor or a hospital without paying out of pocket. Instead, they are covered by compulsory government health insurance.

The CHA sets out the primary objective of the Canadian health care policy which is “to protect, promote and restore the physical and mental well-being of residents of Canada and to facilitate reasonable access to health services without financial or other barriers”.

The CHA establishes criteria and conditions related to health services and health care services that the provinces and territories must fulfill in order to receive the federal cash contribution under the Canada Health Transfer (CTA).

The Federal Government has no direct role in the delivery of medicine in the provinces and territories, so each province and territory has its own independent health insurance program.

Each province and territory in Canada manages its own healthcare system. The provinces/territories receive transfer payments from the federal government based on a funding formula. Each province and territory in turn provides block grants annually to each individual hospital, which in turn allocate funds to its programs and services.

The majority of physicians are paid through a fee-for-service arrangement: a fee schedule is filed with the provincial government for each patient service provided and physicians are reimbursed according to fee schedules negotiated between the provinces and the medical associations.

Over 95% of Canadian hospitals are operated as private non-profit entities with their own governance structures (usually supervised by a community board of trustees or municipalities). They are funded by public monies from provincial budgets. The for-profit sector is comprised of long term care facilities or specialized services such as addiction centers.

Under the Canada Health Act, insured persons are eligible residents of a province or territory, defined as “a person lawfully entitled to be or to remain in Canada who makes his home and is ordinarily present in the province, but does not include a tourist, transient or visitor to the province.” (Canada Health Act)

Insured services are medically necessary hospital, physician and surgical-dental services provided to insured persons (Canada Health Act).

Insured hospital services defined under the CHA include medically necessary in-and-out patient services such as accommodation and meals at the standard or public ward level and preferred accommodation is medically required; nursing service; laboratory, radiology and other diagnostic procedures, together with the necessary interpretations; drug, biologicals and related preparations when administered in the hospital; use of operating room, case room and anesthetic facilities, including necessary equipment and supplies; medical and surgical equipment and supplies; use of radiotherapy facilities; use of physiotherapy facilities; and services provided by person who receive remuneration from the hospital (Canada Health Act).

Insured physician services are defined under the Act as “medically required services rendered by medical practitioners.”

7

Insured surgical-dental services are “services provided by a dentist in a hospital where a hospital setting is required to properly perform the procedure.”

Items not covered under the Canada Health Act which are most often covered by private insurance plans are things such as prescription drugs, dental services, vision care, home care, semi-private or private hospital rooms, assistive devices, ambulance, long-term care chiropractors, cosmetic surgery, etc.)

Today, the system is under a considerable strain due to rising costs, a higher volume of services and a population with a higher proportion of older people. In 2001, the Government of Canada launched a Commission on the Future of Health Care in Canada, asking it to report its recommendations to the Prime Minister by November, 2002. The findings of that commission were detailed in the Romanow Report.

The Romanow Report

Mr. Roy Romanow, former Premier of Saskatchewan, presided over a Royal Commission that toured the country for solutions to save Medicare in the 21st century. His report, published in November of 2002, called for an expansion of Medicare to include catastrophic drug insurance, home care and a banning of private diagnostic imaging clinics.

The Romanow Report rejected private health care delivery, including that provided by workers compensation boards calling it “incompatible” with the “equality of access” principle that forms the foundation of the nation’s public system. He called for changes to the Canada Health Act that would bring all diagnostics services, including MRI and CT scans under the umbrella of the public system. His report recommended that the Act be amended to make all diagnostic scans medically necessary. The report also recommended that Ottawa establish a diagnostic services fund to improve wait times.

None of those recommendations have been implemented, although in 2004, the Government of Canada announced $41 billion over the next 10 years of new federal funding in support of the action plan on health. The new funding will be used to strengthen ongoing federal health support provided through the Canada Health Transfer (CHT), meeting the recommendations from the Royal Commission on the Future of Health Care in Canada, as well as to address wait times to ensure Canadians have timely access to essential health care services.

To accelerate and broaden health renewal and reform, the Government of Canada will take several steps to strengthen the Canada Health Transfer:

·

A total of $3 billion will be invested in 2004-05 and $2 billion in 2005-06 through a supplement to the CHT for provinces and territories, closing the short-term “Romanow gap”.

·

The new CHT level will also reflect an additional $500 million in 2005-06, which will help deepen progress on home care services and catastrophic drug coverage.

·

A new CHT base at $19 billion will be established in 2005-06 exceeding that recommended in the Romanow Report.

·

An escalator of six percent will be applied to the new CHT effective 2006-07 to provide predictable growth in federal support.

This will bring the total cash transfers for health to the provinces and territories from $16.5 billion in 2005-06 to about $24 billion in 2009-10. In that year the CHT will be 45% above the current level.

Combined with the value of CHT tax points, the federal transfer to provinces and territories for health will be approximately $30.6 billion in 2005-06.

8

To reduce wait times, the Government will invest $4.5 billion over the next 6 years, beginning in 2004-05 in the Wait Times Reduction Fund. In 2010-11, $250 million ongoing will be added to the CHT base primarily for health human resources.

The Government will also invest a further $500 million in Medical Equipment. The Government is also providing $700 million over 5 years to improve the health of Aboriginal people through a series of new federal commitments.

Source – Government of Canada – www.scics.gc.ca/cinfo04/800042005_e.pdf

The report also said governments should reconsider the practice of allowing workers compensation agencies to direct pay private clinics to treat injured employees.

If accepted, the recommendations in The Romanow Report would be detrimental to Canada’s expanding industry of private MRI clinics.

Though the Canada Health Care Act provides national guidelines for healthcare, the individual provinces have exclusive jurisdiction over health under the constitution and are free to ignore those guidelines. The counterbalance to this is that the Federal Government requires the provinces to adhere to its guidelines in order to receive federal funding for healthcare. All provinces currently abide by the Canada Health Act.

Funding Declines and Accessibility Challenges

Due to substantial healthcare transfer payment reductions from recent Federal Governments to the provinces and the resulting shortfalls in Provincial Government budgets, combined with rising costs due to an aging population, the quality of care provided has decreased throughout the past two decades.

The decline in federal contributions has had two major consequences. First, hospitals are attempting to maintain the public health care system with substantially reduced resources. Second, the provinces have become less vulnerable to financial penalties imposed by the Federal Government. Given the Federal Government’s reduced financial contribution, any further withholding of funds only serves to further dilute its authority over healthcare. These two factors have enhanced the appeal of private sector health care.   

Commonly referenced current problems are: limited access to diagnostic equipment such as MRI and CT scanners, lengthy wait times for surgeries, and serious physician shortages, especially for general practitioners/family doctors.  

Private Insurance and Managed Care Plans

The administration criterion of the Canada Health Act stipulates that provincial health care plans must be administered by a public agency on a non-profit basis. Private insurance has not been allowed for insured services. But the Canada Health Act does not preclude private insurers from supplementing provincial health care insurance plans. Private plans (private insurance plans, employer–provided health plans) insure services that are not covered or are only partially covered under public plans. The Act does not prevent private health care providers from delivering and being reimbursed for provincially insured health services, so long as extra-billing or user charges are not involved.

Managed care plans in Canada, in general, denote the limitation or re-evaluation of the sort of care that physicians can provide their patients. These are often associated with HMO organizations.

9

In Canada, most companies offer their employees a benefits package (thorough a third party insurer) that includes coverage of a variety of services (life insurance, accident insurance, prescription drug, dental, semi-private hospital, eyeglasses, etc.) In some cases these services are totally funded by the employer and in other situations, the costs are shared with employees.

Several larger corporations are “managing their care plans”. With rising drug costs and the de-listing of some healthcare services by provincial governments across Canada, more and more plan members are looking to their employers for additional healthcare coverage. Progressive plan sponsors (employers) are implementing a variety of initiatives that fall under the managed care umbrella, including wellness programs, managed drug formularies or flexible benefits programs to manage their plan members’ healthcare.

With respect to the number of Canadians covered by such private insurers or managed care organizations, it is impossible to determine. As stated in an article published in Macleans Magazine on April 25, 2006 entitled “The rise of private care in Canada”: “Private providers are rapidly expanding their services across the country but even the industry’s own advocacy group lacks definitive numbers on the size and scope of the private health care sector.” “It is difficult to estimate the full size or scale of private health in Canada. Most provinces track only the services in the public system and even though the private system has an advocacy group known as the Canadian Independent Medical Clinics Association, it does not track the number of practitioners, patients or procedures.”

Canadians who pay for their own services at private clinics are not penalized or prevented from further using the public healthcare system.

Private health insurance has been available in some provinces for many years. Few buy it however because the public healthcare system exists and is much more affordable for Canadians.  

A recent Canadian court decision ruled that a Quebec law, which outlawed private insurance, contravened the Quebec Charter of Rights guaranteeing the right to security of the person. In June, 2005, the Supreme Court of Canada overturned a Quebec law that prevented people from buying private health insurance to pay for medical services available through the publicly funded system. While the ruling only applies to the province of Quebec, it is believed by some that it could fundamentally change the way health care is delivered across the country.

In November, 2005, the Quebec government announced that it would be allowing residents to purchase private medical insurance in accordance with the Supreme Court’s decision.

The “monopoly” effect of Medicare is kept in place not only by the federal Canada Health Act but by a series of supporting provincial legislation – including bans in six provinces on competing private insurance. As a result, we believe the Supreme Courts’ recent decision to overturn Quebec’s insurance ban is important. The Court stated that the ban made patients wait too long for service.   

A physician in private practice may receive all of their income from the public health system. The vast majority of physicians practice entirely in the public sector. Very few physicians practice entirely in the private sector. Some practice both publicly and privately.

Despite the extra expense, some patients do opt for private health care because they perceive the waiting times in the public system to be unacceptably long.  

A New Generation of Private Clinics

Quebec, Alberta, Ontario and British Columbia have allowed private clinics to do X-rays, CT scans and ultrasounds for years. Until recently, none of this was controversial. As long as the providers were operating within the domain of Medicare, few were concerned whether they were private or public. But that changed in the 1990’s when the province of Alberta decided to permit a new generation of clinics. These clinics are offering both Medicare and non-Medicare services.

10

As an example, patients who wished to have a particular type of surgery could book a Medicare appointment and wait weeks or, they could pay out of pocket and get the service faster. Technically, this did not break any laws because the direct-pay patient was allegedly paying for medically unnecessary extras. By the end of the decade, private MRI clinics in Nova Scotia, Alberta, British Columbia and Quebec were offering the so called “medically unnecessary” scans that allowed patients with financial means to pay directly for the services and by-pass the Medicare waiting times.

Health care critics dispute the government’s position that private MRI’s contravene the Canada Health Act.  They point to the federal government’s most recent annual report on the Act, which states “MRI’s are only considered to be insured services under Medicare when they are provided in a hospital or a facility providing hospital care”.  Advocates of private clinics therefore argue that the Canada Health Act allows for private diagnostic services as long as they are not performed in a hospital.

Proposed Reforms

Though most Canadian politicians and citizens acknowledge that there are problems with the present system, the proposed solutions often spark debate. There are those that believe that the problem is simply one of underfunding. They point to the rise of conservative economic policies in Canada from the 1980’s onward as the cause of the degradation of the system. However, it is widely acknowledged that costs associated with the healthcare system have still been creeping upwards as a percentage of total government expenditures. Some politicians have called for an increased role for the private sector in the delivery of hospital Medicare services.

One of the frequent recommendations for reform is to supplement the current public system with a parallel private health care system for those patients who are willing to pay, thus creating what is called a “two-tiered” system.

Proponents of a two-tiered system argue that it would relieve pressure on the public system, thus ensuring its survival. Critics of the two-tiered option say it would erode the public system by destroying its broad base of support and thus increase its costs. Consumers who pay for private services may object to paying taxes to support the public system since they have chosen not to use it, thus weakening support for the public system.  A two-tiered system is a popular concept with many physicians.

In December, 2005, an article entitled “Expert laments lack of private health care debate” published by the CanWest News Service reported that more than half of Canadians indicate that they have no problem with a larger role for private health care. At present, nearly one in every three dollars spent on health care in Canada goes to the private sector. Presently, there is a lack of consensus at both the Federal and Provincial Government levels on the specific issue of health care privatization. As a result, privatization is occurring. Another article in the National Post on June 1, 2004 entitled “Canadians want 2-tier health: poll” indicated: “More than half of Canadians support a parallel private health care system that would let patients pay for speedier service, according to a new poll on an issue that has been largely ignored in the current campaign. The poll found 51% of Canadians favour a two-tier system.” The poll was conducted by Leger Marketing on behalf of The Montreal Economic Institute.

11

The Diagnostic Imaging Opportunity

We believe that the present diagnostic imaging model is not meeting the requirements of all Canadians. In Canada, there is widespread public dissatisfaction with wait times for diagnostic imaging in public hospitals. Waiting lists are long, staffing is poor and the funding is either inadequate or not being allocated in the most optimal way. The following are examples of articles indicating these findings:

·

“The need for diagnostic imaging is growing at the rate of 6% per year, but Dr. Elam says most healthcare spending in recent years has gone towards improving infrastructure or paying staff. Even with $1 billion earmarked for diagnostic imaging machines under (former Prime Minister) Jean Chretien, there still aren’t enough radiologists to run Medicare-funded MRI scanners for more than a few hours a day.” “Widespread dissatisfaction with wait times especially for diagnostic imaging, has helped make healthcare the number one pre-election issue among 80% of voters.” Source for above 2 quotes – “Where MRI? Wonders Health Minister” National Review of Medicine, Volume 1 No. 11, May 30, 2004.

·

“There’s an enormous sense of frustration with the public system. There are close to a million on waiting lists and these people are tired of putting their lives on hold.”  Source - Dr. Brian Day, Canadian Independent Medical Clinics Association – Newsletter, Issue 02/04

·

“But are we satisfied with the level of care and service we receive? A Commonwealth Fund International Health Policy Survey shows that Canadians are dissatisfied with the overall state of the health-care system with 78 percent indicating that the system needs to be fundamentally changed or completely rebuilt.” Source – Healthy Provinces, Healthy Canadians – A Provincial Benchmarking Report – The Conference Board of Canada February 2006  

Proponents of private MRI clinics argue that parallel private MRI clinics will provide competition for public MRI clinics, pushing the public clinics to be more efficient and innovative in delivering service. The medical community asserts that greater savings will be realized in terms of a more productive and healthier population resulting from quicker diagnosis and hence treatment. Also, greater utilization of the equipment will result in lower operating costs.  

Given the current market conditions and our financial projections, Diagnostic Imaging is confident that its MRI clinics will be a viable business operation; however, there can be no assurances given that we will be successful in this market.

Marketing

We believe that there are three distinct segments to the target market for our private MRI clinics.

The first segment is an athletic younger segment of the population, ages 25–45, who experience sports related injuries. They are affluent middle income plus individuals, who are more attuned to getting the “right” health care for their needs. They do not want to experience the long wait times for the public system. The second is the more senior segment of the population – ages 45–75, which are at risk to diseases such as heart disease, strokes, brain injuries or spinal injuries or in need of potential hip or knee operations. We anticipate that the demand in this segment will surge over the next 20 years as the baby boomer generation ages. A third segment is the private insurance companies and workers compensation boards involved in resolving compensation claims.

All requests for scans must be referred by a doctor. Therefore to be successful, a clinic must be well connected with local/regional physicians and family doctors. Diagnostic Imaging plans to partner with a radiologist who is well connected to the medical community in each geographical market. We intend to offer scans at cost to local area doctors and members of their families. This would enable the doctors to experience the clinic on a personal basis, which could lead to recommendations to their patients.

12

We will also recruit a local marketing manager to call on doctors, physicians, workers compensation boards and private insurance organizations in order to promote the services of its clinics.

We plan on creating a brochure featuring our clinics to give to family doctors, physicians, private insurance companies and compensation boards. We will also develop a website which features the clinics, the MRI imaging equipment and outlines of the procedures required for the diagnostic imaging scans.

Diagnostic Imaging plans to conduct periodic educational seminars for the public. Advertisements and announcements will be placed in local newspapers inviting interested parties to attend informational seminars. The purpose of these seminars is twofold: to educate the public on MRI imaging, its purposes and capabilities and to position Diagnostic Imaging as the leader in the magnetic resonance imaging field.

We can give no assurance that we will be successful in implementing our marketing strategies or reaching our target markets.

Capital and Facility Requirements

The capital cost to acquire a high field strength MRI machine varies with the field strength. Prices for an MRI machine will be approximately $2.2 million. Other costs include building renovations for an appropriate facility (approximately $700,000 depending upon size and location) and annual equipment maintenance costs ($150,000 - $180,000).  Overall, we estimate a facility will require $3,320,000.

All MRI machines are calibrated in “Tesla” units. The strength of a magnetic field is measured in Tesla units or Gauss units. The stronger the magnetic field, the stronger the amount of radio signals which can be elicited from the body’s atoms and therefore the higher the quality of MRI images. High field strength machines provide faster and better quality scanning. Measurements of field strength are demonstrated below:

1 Tesla = 10,000 Gauss

Low-Field MRI = Under .2 Tesla (2,000 Gauss)

Mid-Field MRI = .2 to 0.6 Tesla (2,000 Gauss to 6,000 Gauss)

High-Field MRI = 1.0 to 3.0 Tesla (10,000 to 30,000 Gauss)

Early MRI machines were .2 Tesla. Today most machines are either 1.5 Tesla or 3.0 Tesla. At the present time, most of the MRI machines in operation in hospitals and private clinics are 1.5 Tesla machines. The 1.5 Tesla machines are known as the workhorses of the industry. The major medical schools and university based hospitals are the ones that for the most part have the 3.0 Tesla machines.

Higher field strength machines (3.0 Tesla) can do scans quicker and with higher resolution than 1.5 Tesla machines. Higher field strength machines are good for brain imaging and highly detailed images and spectroscopy of small organs such as the prostate or miniscule lesions which lie buried behind complex anatomy.

Tesla machines are ideal in pre-surgical planning to avoid invasive angiography or direct cortical mapping at the time of surgery. 3.0-Telsa machines are also ideal for monitoring the effects of rehabilitation in patients with cognitive impairment after successful acute treatment of acquired brain injury. Some patients do not return to normal after acquired brain injury because of neurological damage to cognitive functions.

13

Diagnostic Imaging International Corp. plans to acquire 1.5 Tesla machines. In terms of types of scans, we will focus primarily on the following. This strength equipment will meet our requirements for scans for:

·

Athletic injuries

·

Accidents

·

Work-related injuries

·

Multiple Sclerosis

·

Abdominal MRI

·

Breast MRI

·

Backs

·

Hip, knee, joints

Each MRI clinic will be about 2,000 square feet. The clinic should be located in or close to an existing medical facility. In 30% of the scans, a contrast agent (gadolinium) must be introduced. This can only be done by a registered physician. We intend to locate our facilities in close proximity to physicians who could perform these injections. We believe this should alleviate scheduling for patients. Scans without a contrast agent do not need a doctor present.

Each facility will require a room that is approximately 22 feet by 25 feet for the MRI scanner. The vendors of MRI equipment will assist with locating and selecting of an appropriate site. The building must be structurally sound in order to support the weight of these MRI machines which is approximately 12,000 lbs. per machine. A control room about 12 feet by 12 feet outside of the scan room is required. The clinic will need at least two change rooms and will require three offices, a boardroom, a kitchenette, a storage area (for linens and supplies), a reception/waiting room and a washroom. The facility will require 220 volt – 3 phase electricity into the building.

We believe that the vendors of MRI equipment will do all of the necessary leasehold improvements to the site in order to have it ready for operation. The room where the MRI machine is to be housed must be insulated – the four walls, ceiling and floor with fine copper mesh (to eliminate RF interference). The equipment is brought on site, usually with the use a crane, through an exterior wall. All exterior and interior walls are then repaired by the vendor. The vendor then sets up, fully inspects and tests the equipment once it is on site in the room. The vendors of the medical imaging equipment said that costs for renovations typically run in the $600,000 - $800,000 range. For budgeting purposes, we used $700,000.

MRI machines use super conducting magnets which utilize a considerable amount of water. As cold water must run through the magnet in order to cool it, a chiller is required for cold water. A chiller costs approximately $40,000. We will also require a Universal Power Supply (UPS) back up for brown outs and black outs. A UPS system will enable the entire MRI system to keep operating for a period of up to 30 minutes, thus allowing the technician to power the system down in an orderly manner as per proper procedures. The cost of one of these UPS systems is approximately $80,000.

In addition to the MRI machines and facilities, we also need office equipment in each facility. We will need various pieces of furniture such as desks, chairs, filing cabinets and various electronic equipment such as copiers, fax machines, telephone systems, computers and security equipment. We currently estimate these costs to be approximately $23,000.

14

We held meetings with two of the major vendors of MRI equipment. Both advised us that it would be necessary to conduct regular maintenance on their equipment. Based on those meetings concerning annual maintenance agreements, we were able to obtain the following:

·

Philips - $160,000 per year – includes weekly on line checks and on site visits 4 times per year. There will be 8 hours of system downtime for onsite maintenance; and,

·

General Electric - $180,000 per year. On site visits are once per month. There will be at least 4 hours of downtime for each on site visit.

The onsite hours can be extended for an additional fee. In addition, both vendors did caution us that there may be occasions when we could be down for an additional period of time while waiting for a part - either at a planned maintenance or an unplanned service call. All replacement parts are included in the maintenance agreements. While the equipment is down, we will be unable to service patients and hence lose potential revenue. The equipment vendor will not pay us for loss of revenues.

We will need to purchase supplies such as Gadolinium, which is a contrast agent that is required for those scans that require a contrast (about 30% of scans). Gadolinium can be purchased from a pharmaceutical company. Smocks, linens, towels can be obtained through a laundry service provider.

We looked at three different vendors of MRI equipment: General Electric Healthcare, Siemens Medical Solutions and Philips Medical Corporation. For the purposes of planning, the General Electric equipment was selected. The following table summarizes the anticipated costs of opening each facility:

MRI machine	$2,200,000
Maintenance agreement	180,000
Chiller	40,000
Universal Power Supply (UPS)	80,000
Facilities renovations	700,000
Office furniture and equipment	23,200
Operating capital during first three months	98,600
Total	$3,321,800

Personnel Requirements

We anticipate that our primary business office will require a Chief Medical Officer (a radiologist) and a Vice President of Finance/Controller.

Each clinic will require the following staff:

·

Radiologist(s) – this can be a partner(s) in the clinic, on a contractual arrangement or a paid employee on staff. We intend to offer the radiologist(s) an ownership interest in their respective clinics as opposed to being on staff or on contract. If are not successful in offering an ownership percentage, the radiologist will receive a regular compensation package plus a percentage of the operating profits or a percentage of the gross invoice value of the scan;

·

MRI Technicians – One of the critical keys to success in this industry is being able to attract and retain good MRI technicians. The technician must be an MRI Certified 1 Technologist. MRI technicians are in high demand. We will have to offer a very competitive compensation package in order to attract quality technicians;

·

Office Manager – An office manager is required for the operation of the clinic. He/she should have some experience in a medical clinic environment. The office manager will do the scheduling, greet patients, perform the invoicing functions, accounting and serve as a backup for the administrative duties of the receptionist/clerical person;

15

·

Receptionist/clerical – Aside from answering phones, the receptionist will type up the Radiologist’s dictations and then fax them to the family doctors; and,

·

Marketing Manager – A good Marketing Manager can make the clinic a success. He/she will have to meet regularly with doctors, physicians, private insurance companies and workers compensation boards.

Government Regulation

We will be directly or indirectly subject to extensive regulation by the Canadian government, provinces and territories in which we conduct our business. In order to open a clinic, it must be licensed by the Ministry of Health and sanctioned by the College of Physicians and Surgeons in the province in which it is located. A Chief Medical Officer (which could be a physician or radiologist) is needed in order to navigate through the lengthy approvals process. There will also be requirements for handling bio-hazardous and radioactive materials and wastes.

In addition, we will need to obtain business permits / licenses, building renovations approvals / permits, zoning restrictions (if new facility) and electrical approvals in the provinces in which we intend to operate. We are currently unaware of the exact government requirements needed to open and operate private diagnostic imaging clinics or the length of time required to obtain approvals. We intend to hire qualified consulting attorneys to obtain the required licenses and permits. The attorneys will be located in the provinces in which we intend to operate our clinics.

If our operations are found to be in violation of any of the laws and regulations to which we or our clients are subject, we may be subject to the applicable penalty associated with the violation, including civil and criminal penalties, damages, fines and the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations, individually or in the aggregate, could adversely affect our ability to operate our business and our financial results. The risk of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management's attention from the operation of our business.

In addition to extensive existing government healthcare regulation, there could be at the federal and provincial levels for reforms affecting the payment for and availability of diagnostic healthcare services. Limitations on reimbursement amounts and other cost containment pressures could result in a decrease in the revenue we expect to receive for each scan we perform. It is not clear at this time what proposals, if any, will be adopted or, if adopted, what effect these proposals would have on our business.

The provinces in which we plan to operate require that the imaging technologists that operate our MRI imaging systems be licensed or certified. Also, each of our clinic sites must meet various health and environmental requirements. Any lapse in our licenses, certifications or accreditations, or those of our technologists, or the failure of any of our clinic sites to satisfy the necessary requirements under the various regulations could adversely affect our operations and financial results.

Competition

We expect to compete with numerous public and private diagnostic imaging clinics. We also expect to compete for the hiring of qualified medical experts and MRI technicians to perform and evaluate the diagnostic imaging scans.  In the future, we expect to compete for qualified consultants, employees and equipment.  Most of our current competitors have, and our future competitors are expected to have, greater resources than us. Therefore, we anticipate that our ability to compete largely will depend on our financial resources and capacity.

Based on various articles we researched, web searches and interviews we conducted we believe there are currently 40 MRI private clinics operating in Canada.

16

Some large Canadian health organizations/companies are involved in MRI diagnostic imaging and there are a few large U.S. based corporations that specialize in diagnostic imaging that could be interested in moving into Canada through mergers or acquisitions.

Our plan is to attract private patients only: an athletic younger segment of the population, who experience sports related injuries; a more senior segment of the population, who are at risk to diseases such as heart disease, strokes, brain injuries or spinal injuries or in need of potential hip or knee operations and private insurance companies and workers compensation boards involved in resolving compensation claims.

ITEM 2. PROPERTY

Property

We are entitled to use office space otherwise provided to our executive officer pursuant to an oral agreement. In addition, we are provided office services as may be required. We currently do not pay any amount for the office space or services. We estimate that the current fair market value of the office space provided by our executive officer to be approximately $4,800 per year. In addition, our executive officer provides us with telephone, office supplies and other minor operating expenses valued at approximately $1,200 per year. These amounts are included in the financial statements presented herein.  We believe that this facility is adequate to meet our corporate headquarter needs until such time as we begin business operations.

Employees

Diagnostic Imaging currently has one employee who is the chief executive officer and chairman of the board. He currently does not receive any cash remuneration for his services. As we implement our business plan we will need additional employees.

ITEM 3. LEGAL PROCEEDINGS

None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

17

PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Common Stock

Our certificate of incorporation authorizes us to issue up to 100,000,000 shares of common stock, par value $.001 per share.  There are 13,267,588 shares issued and outstanding as of March 27, 2009.  

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of the shareholders.  In addition, the holders are entitled to receive dividends ratably, if any, as may be declared from time to time by the board of directors out of legally available funds.  In the event of our dissolution, liquidation or winding-up, the holders of common stock are entitled to share ratably in all the assets remaining after payment of all our liabilities and subject to the prior distribution to any senior securities that may be outstanding at that time.  The holders of common stock do not have cumulative voting rights or preemptive or other rights to acquire or subscribe for additional, unissued or treasury shares. Directors are elected by plurality, but the holders of more than 50% of such outstanding shares, voting at an election of directors are assured of electing all the directors on the board of directors.    All outstanding shares of common stock are, when issued, the shares of common stock offered hereby, are full paid and non-assessable.

Preferred Stock

Diagnostic Imaging is authorized to issue up to 10,000,000 shares of preferred stock, $.001 par value. There are no shares of preferred stock issued and outstanding as of March 27, 2009.

The preferred stock may be characterized as "blank check" stock.  This means that the board of directors, without any action by the stockholders of common stock, have the right, from time to time, to designate some or all of the preferred stock into one or more series, and fix for each series the number of shares, full or limited voting powers, and the designations, preferences, participating, optional and other special rights, and the qualifications, limitations or restrictions of the various aspects of a series. Because of this ability of the board of directors, the preferred stock may be issued quickly and contain provisions that may have an anti-takeover effect, which may not be in some or all of the interests of subordinate preferred stock and common stockholders. In addition, because the board of directors may create convertible and paid-in-kind features for a series of preferred stock, if these features use common stock, Diagnostic I maging may become committed to issue or issue additional common stock from time to time. Any commitment for additional common stock to be issued or actually issued pursuant to the terms of any series of preferred stock may have various results including: (i) an absolute dilutive effect on the current stockholders percentage ownership of the then outstanding common stock and depending on the amount paid for the issued series of preferred stock and payable on conversion, if any amount is to be paid, a financial dilutive effect on previously issued equity securities of the company, including the common stock, (ii) the potential issuance may cause "overhang" issues and impair the marketability or price of the common stock in any public market on which the common stock may be traded, or (iii) may require the company to issue additional common stock at time that is in opportune for Diagnostic Imaging or its  stockholders. The preferred stock does not have any pre-emptive rights.

Transfer Agent

The transfer agent and registrar for our common stock is Olde Monmouth Stock Transfer Co. Inc., 200 Memorial Parkway, Atlantic Highlands, New Jersey, 07716.

Holders

As of December 31, 2008, there were 63 holders of record of the common stock.

18

MARKET FOR COMMON STOCK

Our common stock is approved for listing on the Over-the-Counter Bulletin Board (“OTCBB”) under the stock symbol “DIIG.OB.  

Our common shares are defined as a penny stock under the Securities and Exchange Act of 1934 and rules of the SEC.  These rules impose additional sales practice and disclosure requirements on broker-dealers who sell our shares to persons other than institutional accredited investors and purchasers who are our officers, directors or beneficial owners of 5% or more of our common stock.  Institutional accredited investors include banks, private development companies, certain organizations with assets in excess of $5,000,000 and entities, all the owners of which are accredited investors. For transactions subject to the penny stock rules, a broker-dealer must make a suitability determination for each purchaser and receive a purchaser’s written agreement prior to sale.  In addition, the broker-dealer must make certain mandated disclosures to buyers in transactions of penny stocks.  These disclosures include Schedule 15G which highlights the risks and broker obligations of an investment in penny stock and the rights and remedies of an investor, the bid and offer quotations of the stock, whether the transaction is on a principal basis, the dealers offer and bid prices and whether it has effected transactions at those prices, the compensation that the broker will receive in the transaction as well as compensation to associated persons, and the account statements have similar disclosure requirements.  Consequently, these rules may affect the ability of broker-dealers to make a market in our common stock and may affect the investors’ ability to resell shares purchased in this offering.  These transaction rules also may have a depressive effect on the market because brokers cannot generally recommend an investment in Diagnostic Imaging.  Therefore, in all likelihood, a public market will be slow to develop, if at all.

We have not paid any dividends to date. We can make no assurance that our proposed operations will result in sufficient revenues to enable profitable operations or to generate positive cash flow. For the foreseeable future, we anticipate that we will use any funds available to finance the growth of our operations and that we will not pay cash dividends to stockholders. The payment of dividends, if any, in the future is within the discretion of the Board of Directors and will depend on our earnings, capital requirements, restrictions imposed by lenders and financial condition and other relevant factors.

The trading volume in the common stock has been and is extremely limited. The limited nature of the trading market can create the potential for significant changes in the trading price for the common stock as a result of relatively minor changes in the supply and demand for common stock and perhaps without regard to our business activities.

The market price of our common stock may be subject to significant fluctuations in response to numerous factors, including: variations in our annual or quarterly financial results or those of our competitors; conditions in the economy in general; announcements of key developments by competitors; loss of key personnel; unfavorable publicity affecting our industry or us; adverse legal events affecting us; and sales of our common stock by existing stockholders.

QUARTER ENDED	HIGH		LOW
December 31, 2008	$	0.40	$	0.15
September 30, 2008		0.40		0.39
June 30, 2008		0.40		0.34
March 31, 2008		0.40		0.34

19

We have not paid any dividends to date. We can give no assurance that our proposed operations will result in sufficient revenues to enable profitable operations or to generate positive cash flow. For the foreseeable future, we anticipate that we will use any funds available to finance the growth of our operations and that we will not pay cash dividends to stockholders. The payment of dividends, if any, in the future is within the discretion of the Board of Directors and will depend on our earnings, capital requirements, restrictions imposed by lenders and financial condition and other relevant factors.

RECENT SALES OF UNREGISTERED SECURITIES

In September 2005, the Company sold 80,004 shares of its common stock to 12 individuals for total proceeds of $12,001.

In October 2005, we sold 50,002 shares to 8 individuals for total proceeds of $7,500.

In November 2005, we sold 26,666 shares to 6 individuals for total proceeds of $4,000.

In February 2006, we sold 13,334 shares to 2 individuals for total proceeds of $2,000.

In March, 2006 we sold 26,668 shares to 4 individuals for total proceeds of $4,000.

In November, 2007 we issued 150,000 shares to a corporation and an individual for services valued at $22,500.

All of the sales were through private placements at $0.15 per share. The issuances were made on the basis of an exemption under Section 4(2) of the Securities Act of 1933 to each recipient who represented it was an accredited investor and had the ability to assess an investment in the Registrant.  These transactions conformed either to the requirements of Regulation S or Regulation D.  All of the funds received from these sales were utilized as working capital.

On April 26, 2005, we issued 7,000,000 shares of our common stock to Mr. Richard Jagodnik, our president and sole director for management services rendered. These shares were issued on the basis of an exemption under 4(2) of the Securities Act of 1933.  These shares were valued at $7,000.

As of December 31, 2008 we have 63 shareholders of record of our common stock and believe that there are additional beneficial holders of our common stock who hold through brokerage and similar accounts.

ITEM 6. SELECTED FINANCIAL DATA

Smaller reporting companies are not required to provide disclosure pursuant to this Item.

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Forward Looking Statements

From time to time, we or our representatives have made or may make forward-looking statements, orally or in writing. Such forward-looking statements may be included in, but not limited to, press releases, oral statements made with the approval of an authorized executive officer or in various filings made by us with the Securities and Exchange Commission. Words or phrases "will likely result", "are expected to", "will continue", "is anticipated", "estimate", "project or projected", or similar expressions are intended to identify "forward-looking statements". Such statements are qualified in their entirety by reference to and are accompanied by the above discussion of certain important factors that could cause actual results to differ materially from such forward-looking statements.

20

Management is currently unaware of any trends or conditions other than those mentioned in this management's discussion and analysis that could have a material adverse effect on the Company's consolidated financial position, future results of operations, or liquidity. However, investors should also be aware of factors that could have a negative impact on the Company's prospects and the consistency of progress in the areas of revenue generation, liquidity, and generation of capital resources. These include: (i) variations in revenue, (ii) possible inability to attract investors for its equity securities or otherwise raise adequate funds from any source should the Company seek to do so, (iii) increased governmental regulation, (iv) increased competition, (v) unfavorable outcomes to litigation involving the Company or to which the Company may become a party in the future and (vi) a very competitive and rapidly changing operating envi ronment.

The risks identified here are not all inclusive. New risk factors emerge from time to time and it is not possible for management to predict all of such risk factors, nor can it assess the impact of all such risk factors on the Company's business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Accordingly, forward-looking statements should not be relied upon as a prediction of actual results.

The financial information set forth in the following discussion should be read with the financial statements of Diagnostic Imaging included elsewhere herein.

Plan of Operations

Diagnostic Imaging intends to open and operate Magnetic Resonance Imaging clinics in Canada. We will provide imaging services for fees to private individuals, workers compensation boards, private insurance companies and those not covered by government insured programs.

We currently plan initially to open a clinic in each of Vancouver, British Columbia and Winnipeg, Manitoba.   If we are successful with operations in those locations, then we intend to open a third clinic in Montreal, Quebec. After the implementation of the initial three MRI clinics, we anticipate adding Computed Tomography scan equipment to those facilities and also will evaluate future opportunities for Positron Emission Tomography clinics as well as additional MRI clinics in other locations throughout of Canada.  Such additional locations will depend on an analysis of the various markets, costs, and availability of capital.

We believe it will take approximately 24 months to open and commence operations for an initial clinic.  We expect that once we have a clinic open and operating, subsequent clinics will be able to be opened and operational in three to six months.  The reason for the faster establishment time for later opened clinics will be the ability of the company to obtain approvals more quickly because of its having operations, the work in locating and establishing relations with vendors will have been accomplished, it will have build-out experience and plans, and it will have other experience that will facilitate the development of additional clinics.

21

The first phase of our business plan will focus on raising the required capital. We believe we will need approximately $10,000,000 in order to open our first three diagnostic imaging clinics. We anticipate acquiring the funding through any one or a combination of the sale of our securities in public or private placement transactions, the issuance of convertible debentures or obtaining loans from financial institutions. The Company plans to seek financing during 2009, and expects to commence contacting investment bankers and private placement agents sometime after the beginning of the year.  If there is interest shown by these professionals, it is expected that it would take at least three to six months to locate interested investors and negotiate terms for an investment. Other than commencing to internally identify investment professionals who may be interested in a company our size and our industry, we have not yet contacte d any investment professionals or taken any steps to commence the search for future additional financing. Any new financing is expected to be either common equity or convertible into common equity.  To the extent that common equity is issued, there will be dilution to the then current stockholders of their percentage ownership.  To the extent that securities are convertible, either under convertible notes, preferred stock or warrants, there will likely be a market diluting effect from the overhang.  If the financing is in the form of debt or preferred stock, the company will likely be subject to financial covenants that may restrict its operations and ability to obtain other financing because of consent requirements or various possible earnings requirements, debt to equity ratios and secured party rights, among others.  Moreover, debt and preferred stock will often require interest and dividend payments, which may be accumulated, and limits on declaring dividends on the common stock. &nbs p;The existence of debt and preferred stock with restrictive covenants or priority in security interests that we may have to give, could limit our ability to find financing in the future and to purchase equipment under purchase lien programs. If we are only able to raise less than the $10,000,000, then we will have to scale back our plans, which may be to reduce the number of clinics according to the amount of capital we have.  We expect to incur substantial expenses in the implementation of our plan of operations before we realize any revenues from our efforts. Because we are in the early stages of implementing our business plan, we cannot indicate now if we will ever be profitable. We also anticipate that we will need additional capital to significantly expand our currently planned operations and to pursue other prospects. We may need additional capital in the event we encounter unexpected operating expenses and requirements.

Once we have adequate funding we will begin the second phase of our business plan. This phase will include the hiring of a physician or radiologist as our Chief Medical Officer.  We plan to hire such a person on a part-time or consulting basis in order to keep our costs and commitments to a minimum in the earlier stage of development and implementation of the business plan.  However, depending on the business activities required of this person, we may have to have the person as a full time employee.  We believe that there are persons readily available for this position on a part-time, consulting and full-time basis.  His or her initial responsibility will be to assist in obtaining the appropriate licensing permits. We will be subject to a substantial amount of regulation by the Canadian government, provinces and territories in which we conduct our business. In order to open a clinic, it must be licensed by the Ministry of Health and sa nctioned by the College of Physicians and Surgeons in the province in which it is located. A Chief Medical Officer is needed in order to navigate through the lengthy approvals process. There will also be requirements for handling bio-hazardous and radioactive materials and wastes. We believe the licensing process will require from 12 to 18 months and it is expected to cost $50,000.  The costs will be associated with salaries, engaging consultants for the application process, filing fees and other costs that may arise.

22

The third phase of our plan will entail locating clinic sites and obtaining the necessary diagnostic imaging and other equipment. Each MRI clinic will require approximately 2,000 square feet. Ideally, the clinic should be located in or close to an existing medical facility for the convenience of customers.  We intend to lease the premises for our clinics. We anticipate that each site will require extensive renovations. The building must be structurally sound in order to support the weight of a MRI machine which is approximately 12,000 lbs. per machine. Each facility will require a separate insulated room for the MRI scanner, a control room, clothing change rooms, offices, storage area, a reception/waiting room and a washroom. Each facility will require 220 volt – 3 phase electricity into the building. We anticipate that the renovation work alone will be from $600,000 to $800,000 per facility.  We may receive rent c oncessions from landlords for renovations, the amounts of which would depend on the length of the term of the lease. The vendors of MRI equipment advised us that they will do all of the necessary leasehold improvements to the site in order to have it ready for operation. This includes taking down existing exterior and interior walls. The room where the MRI machine is to be housed must be insulated – the four walls, ceiling and floor have to be insulated with fine copper mesh (to eliminate RF interference). The equipment is brought on site, usually with the use a crane, through an exterior wall. All exterior and interior walls are then repaired by the vendor. The vendor then sets up, fully inspects and tests the equipment once it is on site in the room. Two different vendors of medical imaging equipment said that costs for renovations typically run in the $600,000 - $800,000 range. We also anticipate having to obtain building permits and similar permissions, however, this requirement may be reduced or al leviated if we are located in medical office buildings where it is common that the landlord has obtained or will participate in obtaining necessary permits.

The capital cost to acquire a high field strength MRI machine varies with the field strength. All MRI machines are calibrated in “Tesla” units. The strength of a magnetic field is measured in Tesla units or Gauss units. The stronger the magnetic field, the stronger the amount of radio signals which can be elicited from the body’s atoms and therefore the higher the quality of MRI images. High field strength machines provide faster and better quality scanning. We anticipate an MRI machine will cost about $2.2 million per machine and annual equipment maintenance costs range from $150,000 to $180,000 per machine.  MRI machines use super conducting magnets which utilize a considerable amount of water. As cold water must run through the magnet in order to cool it, a chiller is required for cold water. A chiller costs approximately $40,000. We will also require a Universal Power Supply (UPS) back up for brown outs and black outs. The cost of a UPS system is approximately $80,000.  We believe that suppliers of these components offer purchase financing.  For a start up operation, such financing is anticipated to be limited to a smaller portion of the acquisition cost and may be at higher rates than offered to operating companies, and may require letters of credit or guarantees.  We plan to explore opportunities for such financing and evaluate it in light of its cost and the availability of funds to the company and its working capital.  Initially, we are planning on being required to purchase such machinery without financing.

In addition to the MRI machines and facilities, we also need office equipment in each facility. We will need various pieces of furniture such as desks, chairs, filing cabinets and various electronic equipment such as copiers, fax machines, telephone systems, computers and security equipment. We currently estimate these costs to be approximately $23,000.

We will need to purchase supplies such as Gadolinium, which is a contrast agent that is required for those scans that require a contrast (about 30% of scans). Gadolinium can be purchased from a pharmaceutical company, and we believe it is reasonably available in the market place. Smocks, linens, towels can be obtained through a laundry service provider.  These supplies will not be required until the clinic is near to operational and can be sourced at that time.

23

Once we have obtained the clinic sites and equipment we will begin staffing each of our facilities. Each clinic will require a radiologist (who will also serve as the Chief Medical Officer of the facility), MRI technicians, office manager, receptionist and a marketing manager at minimum. In addition to overseeing the licensing functions, the radiologist will be responsible for reading the scans. The MRI technician will perform the imaging scans. The office manager will do the scheduling, greet patients and perform the invoicing and accounting functions. The receptionist will be responsible for answering the phones and typing the radiologist’s dictations and faxing them to the family doctors.  The marketing manager will be responsible for meeting regularly with doctors, physicians, private insurance companies and workers compensation boards in order to promote the Company’s business.  We anticipate that our pri mary business office will require a Chief Medical Officer (a radiologist) and a Vice President of Finance/Controller.  We believe these persons are available for hire in the cities we plan to locate our facilities.  However, because of the demand for these persons and the fact that training facilities are not graduating as many as the market requires the ability of any potential employer to find these persons are often difficult.  Therefore, we anticipate having to compete for such hires, and we may have to offer substantially better employment packages than our competitors.  We believe that for our clinics to operate efficiently, these persons will have to be direct and full time employees.  As a result the company will have to make substantial employment commitments.  Notwithstanding, the company will seek to use part-time employees and outsource providers where available, cost effective and conducive to the standards of service that will enhance our operations and reputations .

No assurance can be given that Diagnostic Imaging will be successful in implementing any phase or all phases of the proposed business plan. Implementation depends on many factors, including, among other things, having enough funds when needed for each phase, acquiring the appropriate operating licenses, achieving market acceptance for our services, effective marketing, and developing a competent and sufficient management and medical staff team. If we are unable to raise the full $10,000,000 that we believe is needed in order to open three fully operational clinics we will have to scale back our operational plans. Such scale backs could include opening only one or possibly two clinics, leasing the MRI equipment as opposed to the purchase of the equipment and employ less than the number of personnel than we anticipate that we will need to staff our operations.

If management is unable to implement its proposed business plan, it does not have any alternative proposals. In that event, investors should anticipate that their investment will be lost and there will be no ability to profit from the business opportunity of our proposed diagnostic imaging services operations.

Financial Condition and Changes in Financial Condition

Overall Operating Results:

The Company had no revenues from inception through the year ended December 31, 2008.

Operating expenses for the year ended December 31, 2008 totaled $65,976. We incurred $29,390 in professional fees primarily for the audit and reviews of our financial statements and legal and consulting fees.  The remaining $36,586 in expenses was incurred for general business operations.

Operating expenses for the year ended December 31, 2007 totaled $74,802. We incurred $32,419 in professional fees primarily for the audit and reviews of our financial statements and legal and consulting fees. We incurred $32,500 in marketing fees. The remaining $9,883 in expenses was incurred for general business operations.

We believe we will incur substantial expenses in the near term as we initiate our business plan.

Liquidity and Capital Resources:

Since inception to December 31, 2008, we have funded our operations from the sale of our common stock.

24

In September, 2005, the Company sold 80,004 shares of its common stock to 12 individuals for total proceeds of $12,001. In October, 2005, we sold 50,002 shares to 8 individuals for total proceeds of $7,500. In November, 2005, we sold 26,666 shares to 6 individuals for total proceeds of $4,000. In February, 2006, we sold 13,334 shares to 2 individuals for total proceeds of $2,000. In March, 2006 we sold 26,668 shares to 4 individuals for total proceeds of $4,000. In November of 2007 we issued 150,000 shares for services valued at $22,500. All of the sales were through private placements at $0.15 per share. We utilized the funds received for working capital.

As of December 31, 2008, our assets totaled $5,117, which consisted of cash balances, a deposit on a potential acquisition and office equipment. Our total liabilities consisted of accounts payable of $70,618 and a note payable to our majority shareholder in the amount of $66,207. We had an accumulated deficit of $249,671 and had a working capital deficit of $136,397.

Our independent auditors, in their report on the financial statements, have indicated that the Company has experienced recurring losses from operations and has minimum cash, which raises substantial doubt about our ability to continue as a going concern. Management has made a similar note in the financial statements.  As indicated herein, we have need of capital for the implementation of our business plan, and we will need additional capital for continuing our operations over the longer term.  Management believes that at this stage of the operations of the Company, where we have minimal operations, we will be able to obtain sufficient amounts for day to day operations for the near term.  However, thereafter, unless it is able to raise working capital, it is likely that the Company either will have to cease operations or substantially change its methods of operations or change its business plan.

We do not have sufficient working capital to begin the implementation of our business plan. We anticipate that we will need to raise at least $10,000,000 to open our first three diagnostic imaging clinics. We currently do not have any sources for this funding.  We anticipate raising the required funding through the sale of our securities in public or private placement transactions, and/or the issuance of convertible debentures and/or loans from financial institutions. We have no commitments at this time and we cannot give any assurances that we will be successful in raising adequate funds in order to implement our business plan.  We will require additional capital in order to begin operations for additional clinics in the future.

New Accounting Pronouncements

Diagnostic Imaging does not expect the adoption of recently issued accounting pronouncements to have a significant impact on Diagnostic Imaging’s results of operations, financial position, or cash flow.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Smaller reporting companies are not required to provide disclosure pursuant to this Item.

25

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS

TABLE OF CONTENTS

Report of Independent Registered Public Accounting Firm

  F-1

Consolidated Balance Sheets as of December 31, 2008 and 2007

  F-4

Consolidated Statements of Expenses for the years ended December 31, 2008 and 2007

and the period from March 14, 2002 (inception) to December 31, 2008

  F-5

Consolidated Statements of Changes in Stockholders’ Equity (Deficit) from March 14, 2002

(inception) to December 31, 2008

  F-6

Consolidated Statements of Cash Flows for the years ended December 31, 2008 and 2007

and the period from March 14, 2002 (inception) to December 31, 2008

  F-7

Notes to Consolidated Financial Statements

  F-8

26

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors

 Diagnostic Imaging International Corp.

 We have audited the accompanying consolidated balance sheets of Diagnostic Imaging International Corp. (a development stage company) as of December 31, 2008 and 2007, and the related statements of expenses, changes in stockholders' equity (deficit), and cash flows for the years then ended. The financial statements for the period from March 14, 2002 (inception) through December 31, 2006, were audited by other auditors whose report dated March 21, 2007 expressed unqualified opinions on those statements. The consolidated financial statements for the period May 14, 2002 (inception) through December 31, 2006, include total revenues of $0 and a net loss of $108,893. Our opinion on the consolidated statements of expenses, stockholders' deficit and cash flows for the period March 14, 2002 (inception) through December 31, 2006, insofar as it relates to amounts for prior periods through December 31, 2006, is based solely on the reports of other auditors. These financial statements are the r esponsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

 We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overa ll financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

 In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Diagnostic Imaging International Corp. as of December 31, 2008 and 2007, and the results of its expenses, changes in stockholders' equity (deficit) and cash flows for the periods then ended in conformity with accounting principles generally accepted in the United States of America.

 The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 5 to the financial statements, the Company has insufficient working capital, which raises substantial doubt about its ability to continue as a going concern. Management's plans regarding those matters also are described in Note 5. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 /s/ M&K CPAS, PLLC

 www.mkacpas.com

 Houston, Texas

March 27, 2009

F-1

Report of Independent Auditors

Board of Directors

Diagnostic Imaging International Corp

We have audited the accompanying consolidated balance sheet of Diagnostic Imaging International Corp (A Development Stage Company) as of December 31, 2006, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for the years ended December 31, 2006, 2005 and the period since inception on March 14, 2002 to December 31, 2006.  These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit.  

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating t he overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Diagnostic Imaging International Corp as of December 31, 2006 and the consolidated results of their operations and cash flows for the years ended December 31, 2006, 2005 and since inception in 2002 through December 31, 2006 in conformity with generally accepted accounting principles applied on a consistent basis after restatement for the change in the method of accounting for contributed services as described in Note 8 to the financial statements.

The accompanying consolidated financial statements have been prepared assuming that Diagnostic Imaging International Corp. will continue as a going concern. As discussed in Note 6 to the consolidated financial statements, Diagnostic Imaging has suffered recurring losses from operations and has minimum cash, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Robnett & Company LP

Austin, Texas

March 21, 2007

/s/ Robnett & Company LP

F-2

Robnett & Company, LP	13809 Research Blvd. Ste. 900 Austin, TX 78750 Ph. 512.258.8584 Fax 512.258.9045	www.robnettcpa.com
Certified Public Accounts & Consultants

May 11, 2009

Diagnostic Imaging, Inc.

Mr. Richard Jagodnik

Dear Mr. Jagodnik,

As discussed in auditing standards issued by the PCAOB, specifically AU 508, predecessor auditor’s written permission is required to reference reliance on opinions issued by the predecessor auditor.  By way of this letter, we grant permission to your successor auditors to reference our opinion on the financial statements of Diagnostic Imaging, Inc. for the period since inception on March 14, 2002 to December 31, 2006.  Further, permission is also given for our opinion as well as the audit report issued by Robnett & Company, LP for Diagnostic Imaging, Inc. for the period since inception on March 14, 2002 through December 31, 2006 be included in the successor auditor’s opinion and report for the year ending December 31, 2008.

Sincerely,

/s/ Robnett & Co LP

Robnett & Company, LP

F-3

Diagnostic Imaging International Corp.

(A Development Stage Company)

Balance Sheets

As at December 31, 2008 and 2007

Assets	2008		2007
Current Assets
Operating Cash – US Bank	$	380	$	937
Operating Cash – Canada Bank (in US dollars)		48		324
Total Current Assets		428		1,261
Fixed Assets
Computer Equipment		800		800
Accumulated Depreciation		(200)		(40)
Total Fixed Assets		600		760
Other Assets
Deposit		4,089		-
Total Other Assets		4,089		-
Total Assets	$	5,117	$	2,021
Liabilities
Current Liabilities
Accounts payable	$	70,618	$	47,038
Note Payable to Shareholder		66,207		31,800
Total Current Liabilities		136,825		78,838
Long-Term Liabilities
Total Long-Term Liabilities		-		-
Total Liabilities		136,825		78,838
Shareholders’ Deficit
Preferred stock, .001 par value, 10,000,000 shares authorized, none issued or outstanding
Common stock, .001 par value; 100,000,000 shares authorized, 9,946,674 issued and outstanding		9,947		9,947
Additional paid-in capital		107,908		96,553
(Deficit) accumulated during the development stage		(249,671)		(183,695)
Comprehensive income accumulated during development stage		108		378
Total Shareholders’ Deficit		(131,708)		(76,817)
Total Liabilities and Shareholders’ Deficit	$	5,117	$	2,021

See Accompanying Notes and Accountants’ Report

F-4

Diagnostic Imaging International Corp.

(A Development Stage Company)

Statements of Expenses

For the year ended December 31,

					March 14, 2002 (date of inception) to December 31,
	2008		2007		2008
Sales	$	-	$	-	$	-
Total Sales		-		-		-
Operating Expense
Administration Fees		17,456		7,578		60,933
Bank Service Charges		186		210		1,118
Depreciation Expense		160		40		200
Finance Charges		10,168		2,055		12,224
Licenses, Fees, Permits		-		-		671
Management Fees		-		-		7,000
Marketing Fee		2,832		32,500		35,332
Office Supplies		4,388				4,388
Professional Fees		29,390		32,419		125,984
Telephone		1,313		-		1,314
Travel		83		-		507
Total Expenses		65,976		74,802		249,671
Operating Income (Loss)		(65,976)		(74,802)		(249,671)
Other Comprehensive Income (Loss)
Gain (Loss) on Foreign Exchange		(270)		585		108
Total Other Comprehensive Income (Loss)		(270)		585		108
Comprehensive Income (Loss)	$	(66,246)	$	(74,217)	$	(249,563)
Income (Loss)  per share		(0.0066)		(0.0075)
Weighted average number of shares		9,946,674		9,852,564

See Accompanying Notes and Accountants’ Report

F-5

Diagnostic Imaging International Corp.

(A Development Stage Company)

Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

From Inception March 14, 2002 to December 31, 2008

					Accumulated
			Additional		Other
	Common Stock		Paid-in	Accumulated	Comprehensive
	Amount	Shares	Capital	Deficit	Loss	Total
	$		$	$	$	$
14-Mar-02
Proceeds from Sale of stock	2,600	2,600,000	10,400			13,000
Additional Paid in Capital			4,500			4,500
Comprehensive income ( Loss)					(16)	(16)
Net Income ( Loss)				(9,823)		(9,823)
31-Dec-02	2,600	2,600,000	14,900	(9,823)	(16)	7,661
Proceeds from Sale of stock	-		-			-
Additional Paid in Capital	-		6,000			6,000
Comprehensive income ( Loss)	-		-		265	265
Net Income ( Loss)	-		-	(7,388)		(7,388)
31-Dec-03	2,600	2,600,000	20,900	(17,211)	249	6,538
Proceeds from Sale of stock	-		-			-
Additional Paid in Capital	-		6,000			6,000
Comprehensive income ( Loss)	-				100	100
Net Income ( Loss)				(6,528)		(6,528)
31-Dec-04	2,600	2,600,000	26,900	(23,739)	349	6,110
Proceeds from Sale of stock	7,157	7,156,674	23,343			30,500
Additional Paid in Capital			6,000			6,000
Comprehensive income ( Loss)					(152)	(152)
Net Income ( Loss)				(17,593)		(17,593)
31-Dec-05	9,757	9,756,674	56,243	(41,332)	197	24,865
Proceeds from Sale of stock	40	40,000				40
Additional Paid in Capital			11,960			11,960
Comprehensive income ( Loss)					(404)	(404)
Net Income ( Loss)				(67,561)		(67,561)
31-Dec-06	9,797	9,796,674	68,203	(108,893)	(207)	(31,100)
Shares issued for services	150	150,000	22,350			22,500
Services contributed by shareholder	-		6,000			6,000
Comprehensive income ( Loss)	-				585	585
Net Income ( Loss)	-			(74,802)		(74,802)
31-Dec-07	9,947	9,946,674	96,553	(183,695)	378	(76,817)
Imputed interest on shareholder loan			5,355			5,355
Services contributed by shareholder	-		6,000			6,000
Comprehensive income ( Loss)	-				(270)	(270)
Net Income ( Loss)	-			(65,976)		(65,976)
31-Dec-08	9,947	9,946,674	107,908	(249,671)	108	(131,708)

See Accompanying Notes and Accountants’ Report

F-6

Diagnostic Imaging International Corp.
(A Development Stage Company)
Statement of Cash Flows

	For the Twelve		For the Twelve		14-Mar-02
	Months ended		Months ended		(date of Inception)
	Dec. 31, 2008		Dec. 31, 2007		to Dec. 31, 2008
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$	(65,976)	$	(74,802)	$	(249,671)
Interest imputed on shareholder loan		5,355				5,355
Adjustments to Reconcile Net Income (used in) operating activities:
Shares issued for services				22,500		22,500
Depreciation and Amortization		160		40		200
Decrease (Increase) in:
Accounts Payable		23,580		12,945		70,618
Deposit		(4,089)		-		(4,089)
Net Cash Provided By (Used in) Operating Activities		(40,970)		(39.317)		(155,087)
CASH FLOWS FROM INVESTING ACTIVITIES
Fixed Assets		-		-		-
Proceeds from sale of available-for-sale securities		-		-		-
Net Cash Provided By (Used in) Investing Activities		-		-		-
CASH FLOWS FROM FINANCING ACTIVITIES
Notes Payable Borrowings – Related Party		34,407		31,000		65,407
Services Contributed by Shareholder		6,000		6,000		46,460
Proceeds From Sale of Stock		-		-		43,540
Net Cash Provided By (Used in) Financing Activities		40,407		37,000		155,407
Gain (Loss) on Foreign Exchange		(270)		585		108
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		(833)		(1,732)		428
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		1,261		2,993		-
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$	428	$	1,261	$	428

See Accompanying Notes and Accountants’ Report

F-7

Diagnostic Imaging International Corp.

 (A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

December 31, 2008

Note 1. Organization and Summary of Significant Accounting Policies

Organization and Basis of Presentation

Diagnostic Imaging International Corp., the “Company”, “Diagnostic” or the “Registrant”) A Nevada Corporation was incorporated on December 12, 2000 to engage in the transaction of any and all lawful businesses for which corporations may be incorporated under the Nevada Business Corporation Act.  Prior to August 19, 2005, the Company was named Galloway Investments Corp.  Upon inception, Galloway Investment Corp created a subsidiary Galloway Properties Corp that was effectively dissolved in August 2005.  The company does not currently have any subsidiaries.

As of December 31, 2008 the Company is in the development stage.

Basis of Presentation

These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.

Use of Estimates

The preparation of the Company’s consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.  Actual results could differ from these estimates.

Cash and Cash Equivalents

The company considers all investments with maturities of ninety days or less when purchased to be cash equivalents.  There were no cash equivalents at December 31, 2008 and 2007, respectively.

Income Taxes

The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards (SFAS) No. 109, Accounting for Income Taxes.  This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

Loss Per Share

The Company follows the provisions of SFAS No. 128, Earnings Per Share.  Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period.  Basic and diluted loss per share are the same as all potentially dilutive securities are anti-dilutive.

F-8

Segments

In 1997, the Financial Accounting Standards Board issued SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information, which establishes reporting standards for a company’s operating segments in annual financial statements and the reporting of selected information about operating segments in financial statements.  The adoption of SFAS No. 131 had no effect on the disclosure of segment information as the Company is considered to be a developmental stage company thus far without segments.

Foreign Currency Translation

Assets and liabilities of the Company’s foreign operations are translated into U.S. dollars at the exchange rate in effect at the balance sheet date.  Revenue and expenses are translated at average rates in effect during the period.  The resulting translation adjustment is reflected as accumulated other comprehensive income (loss), a separate component of shareholders’ equity on the consolidated balance sheets.  The Company recognized a loss of $270 in 2008 and a gain of $585 in 2007.

Financial Instruments

The Company’s financial instruments, when valued using market interest rates, would not be materially different from the amounts presented in the consolidated financial statements.

Property and Equipment

Property and equipment are valued at cost.  Additions are capitalized and maintenance and repairs are charged to expense as incurred.  Gains and losses on dispositions of equipment are reflected in operations.  Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are 2 to 10 years.

Stock Based Compensation

Effective January 1, 2006, the Company adopted SFAS 123R, Share-Based Payment, (“SFAS 123R”).  SFAS 123R requires that the fair value compensation cost relating to share-based payment transactions be recognized in financial statements.  Under the provisions of SFAS 123R, share-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized over the employee’s requisite service period, which is generally the vesting period.   The Company adopted the fair value recognition provisions of SFAS No. 123R using the modified prospective transition method.  Under this transition method, stock-based compensation cost is recognized beginning January 1, 2006, for all options granted after the date of adoption as well as the unvested portion of previously granted options based on the estimated fair value.   As at December 31, 2008 the Company had no options outstanding.

Recently Issued Accounting Pronouncements

In September 2006, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 157, Fair Value Measurements, which defines fair value, establishes a framework for measuring fair value in U.S. generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS No. 157 does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. This statement is effective for the Company beginning January 1, 2008. The Company is currently assessing the potential impact that adoption of SFAS No. 157 will have on its financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities-Including an Amendment of SFAS No. 115. SFAS No. 159 permits entities to choose to measure many financial instruments and certain other items at fair value. Most of the provisions of this statement apply only to entities that elect the fair value option. This statement is effective for the Company beginning January 1, 2008. The Company is currently assessing the potential impact that adoption of SFAS No. 159 will have on its financial statements.

F-9

In December 2007, the FASB issued SFAS No. 141R, Business Combinations, the purpose of which is to improve the relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial reports about a business combination and its effects. SFAS No. 141R retains the fundamental provisions of SFAS No. 141, which it replaces, but is broader in scope than SFAS No. 141. This statement is effective for the Company beginning January 1, 2009. Earlier application is prohibited. The Company is currently assessing the potential impact that adoption of SFAS No. 141R will have on its financial statements.

The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Development Stage Operations

The corporation was incorporated in December 2000 but did not have any activity until spring of 2002.  In 2002, the original articles of incorporation were amended to increase the authorized number of shares of common stock from 1,000,000 to 100,000,000 and authorized 10,000,000 in preferred stock.  The company remained dormant until August of 2005 when the original shareholders sold their shares to the now majority shareholders at which time the company filed another amended articles of incorporation with the state of Nevada changing the name of the corporation from Galloway Investments Inc. to Diagnostic Imaging International Corp.  It is the intent of the current majority shareholders to operate a chain of MRI clinics across Canada after it raises the necessary capital.  Consequently, until such time as the capital is raised and the company starts operations there is a good likelihood that the company could have going concern issues.  The Company classifies i tself as a Development Stage Company pursuant to SFAS Statement 7.

Note 2.

Property and Equipment

Property and equipment are stated at cost.  Depreciation is calculated on the accelerated method over the estimated useful life of the assets.  At December 31, 2008 and 2007, the major class of property and equipment are as follows:

	2008	2007	Estimated useful lives
Computer/Office Equip	800	800	5 years
Less: Accumulated Depreciation	(200)	(40)
Net Book Value	600	760

Depreciation expense was $160 for 2008 and $40 for 2007.

Note 3.

 Income Taxes

As of December 31, 2008, the company had estimated federal net operating loss carry-forwards approximating $50,954.  The net operating losses will expire beginning in 2017 if not utilized.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.  The company’s deferred taxes are attributable to the net operating loss carryforwards.  The deferred tax asset equals $13,655 and $17,201 at December 31, 2008 and 2007, respectively.

A valuation allowance has been established equal to the net deferred tax asset due to the uncertainties regarding their realization as a result of this being a developmental company, which has little certainties of future profits.  As of December 31, 2008, the company reduced net income by the amount of the valuation allowance.

F-10

Note 4. Related Party Transaction

During 2008, Richard Jagodnik (an officer and shareholder of the company), loaned the Company $34,407.  The note is non-interest bearing and payable on demand.  The balance as of December 31, 2008 and 2007 is $66,207 and $31,800, respectively.  Interest has been imputed at 6.1% and 4.7% for transactions in 2007 and 2008 respectively, resulting in additional interest expense and additional paid in capital of $5,355 for the year ended December 31, 2008.

Note 5. Going Concern

As shown in the accompanying financial statements, the company incurred comprehensive net losses of $60,891 and $74,217 at December 31, 2008 and 2007, respectfully.  These conditions raise substantial doubt as to the company’s ability to continue as a going concern.  These financial statements do not include any adjustments that might be necessary if the company is unable to continue as a going concern.

Note 6.  Common Stock Transactions

During 2007, the Company issued 150,000 shares for marketing services valued at $22,500.

Note 7. Subsequent Events

Subsequent to its year-end, the Company closed on financing and the purchase of Canadian Teleradiology Services, Inc. (“CTS”).  CTS is a provider of remote Teleradiology services to hospitals in Canada on an on-call, 24-hour basis.  CTS transmits radiological scans from local hospitals to radiologists in larger centers who read and report on the scans.  

In February and March of 2009, the Company raised $378,136.78 and issued 2,520,914 common shares through a private placement.

F-11

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in Company reports filed under the Exchange Act is accumulated and communicated to management, including our chief executive officer (who is also our principal financial and accounting officer) (the “Certifying Officer”), as appropriate to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, the Certifying Officers carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of December 31, 2008. Their evaluation was carried out with the participation of other members of the Company’s management. Based upon their evaluation, the Certifying Officers concluded that the Company’s disclosure controls and procedures were not effective.

The Company’s internal control over financial reporting is a process designed by, or under the supervision of, the Certifying Officers and effected by the Company’s Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with generally accepted accounting principles. Our management, including our Certifying Officer does not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud.  A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.  Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their co sts. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.  To address the material weaknesses, we performed additional analysis in an effort to ensure our consolidated financial statements included in this annual report have been prepared in accordance with generally accepted accounting principles.  Accordingly, management believes that the financial statements included in this report fairly represent in all material respects our financial condition, results of operations and cash flows for the periods presented.

36

Management’s Report on Internal Control over Financial Reporting

Management of Diagnostic Imaging International Corp. (“Diagnostic” or “the Company”) is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting for the Company.  As defined by the Securities and Exchange Commission (Rule 13a-15(f) under the Exchange Act of 1934, as amended), internal control over financial reporting is a process designed by, or under the supervision of the Company’s principal executive and principal financial officers and effected by its Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the consolidated financial statements in accordance with U.S. generally accepted accounting principles.

Under the direction of the Chief Executive Officer, management began an evaluation of the effectiveness of the system of internal control over financial reporting based on the framework in Internal Control Integrated Framework, published by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  Management is aware that there is a lack of segregation of duties due to the small number of employees dealing with general administrative and financial matters.  However, at this time, management has decided that taking into account the abilities of the employees now involved, the control procedures in place and its awareness of the issues presented, the risks associated with such lack of segregation are low and the potential benefits of additional employees to clearly segregate duties do not justify the substantial expenses associated with such increases.  Management will periodically reevaluate this situation, and report to the reg istered public accounting firm of the Company about this condition.  We have identified the following material weaknesses:

1.

 As of December 31, 2008, we did not maintain effective controls over the control environment.  Specifically, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 207(d)(5)(ii) of Regulation S-B.  Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.

2.

As of December 31, 2008, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.

Because of these material weaknesses, management has concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2008, based on the criteria established in “Internal Control-Integrated Framework” issued by COSO.

We are evaluating how we will remediate these material weaknesses and will provide the required disclosure when appropriate.

Changes in Internal Control over Financial Reporting

There has been no change in the Company’s internal control over financial reporting that occurred in the year ended December 31, 2008, that has materially affected, or is reasonably likely to affect, the Company’s internal control over financial reporting.

Independent Registered Accountant’s Internal Control Attestation

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting.  Management’s report was not subject to attestation by the Company’s registered accounting firm pursuant to temporary rules of the SEC that permit only management’s report in this annual report.

37

ITEM 9B. OTHER INFORMATION

On March 11, 2009, we notified Robnett & Company LP (“Robnett”), our former independent registered public accounting firm, that we had engaged a new independent registered public accounting firm and thereby were terminating our relationship with Robnett. Our consolidated financial statements for the years ended December 31, 2007 and 2006 were audited by Robnett.  Robnett’s reports on our financial statements for those two fiscal years did not contain an adverse opinion, a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles, except that substantial doubt was raised as to our ability to continue as a going concern in each of the reports.

There is no other information to be disclosed in a report on Form 8-K during the fourth quarter of the year covered by this Form 10-K that has not been previously filed with the Securities and Exchange Commission.

38

PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, CONTROL PERSONS AND CORPORATE GOVERNANCE; COMPLIANCE WITH SECTION 16 (a) OF THE EXCHANGE ACT.

The following table sets forth information concerning the sole director and executive officer of Diagnostic Imaging International Corp. and their age and position. Each director holds office until the next annual stockholders' meeting and thereafter until the individual's successor is elected and qualified. Officers serve at the pleasure of the board of directors.

NAME	AGE	POSITIONS
Richard Jagodnik	40	Chief Executive Officer, President and Chairman

The sole officer and director of Diagnostic Imaging is Richard Jagodnik. Mr. Jagodnik is 40 and a Chartered Accountant in Canada. He graduated from Concordia University in 1990 with a Bachelor of Commerce degree with a major in accounting. Mr. Jagodnik received his Chartered Accountant certification in 1993. From 1997 through 2005, he was the Vice President of Finance for Interesting Displays & Ideas, a Montreal based manufacturing organization. From 1990 through 1997, Mr. Jagodnik worked in public practice with Friedman and Friedman, Chartered Accountants. With his financial background he has acquired experience in strategic planning, budgeting, project and contract management and organizational planning.

During the last five years, no officers or directors have been involved in any legal proceedings, bankruptcy proceedings, criminal proceedings or violated any federal or state securities or commodities laws or engaged in any activity that would limit their involvement in any type of business, securities or banking activities. The amount of time that Mr. Jagodnik devotes to the business affairs depends on the needs of the company from time to time. Currently, Mr. Jagodnik spends approximately 15% of his business time on the affairs of the company, but this is likely to increase as implementation of the business plan progresses.  If the business plan is delayed or revised to be less than described herein, the amount of time he will spend on the affairs of the company will decrease.

During the last five years, no officers or directors have been involved in any legal proceedings, bankruptcy proceedings, criminal proceedings or violated any federal or state securities or commodities laws or engaged in any activity that would limit their involvement in any type of business, securities or banking activities.

Directors

Each director holds office until the next meeting of stockholders or until his successor is duly appointed and qualified.  Directors do not receive any compensation for their services at this time. In the future, if Diagnostic Imaging has non-employee directors, it expects it will provide a compensation package primarily based on stock options and reimbursement for direct expenses.  Such compensation package will be determined at that time.

39

Board of Directors

Our board of directors considers all major decisions, including those that might be overseen by an audit committee and a nominations committee.  For example, the board oversees the accounting and financial reporting processes and audits of the financial statements.  It selects and appoints the independent auditors and assesses their qualifications and independence.  The board reviews the corporate governance standards and establishes certain guidelines within the context of having a single officer and director.  If and when there are additional employees and directors, such guidelines will be reviewed and adjusted accordingly.  The board determines those persons who will be nominated for election as directors.  The board anticipates that if the board is expanded, the initial selection of persons to fill newly created directorships will be at the sole determination of the then current directors, which will initially be only Mr . Jagodnik.  The board will consider suggestions from shareholders which may be communicated directly to the board.  Persons identified as potential board members should have an appropriate business background relevant to the proposed business of Diagnostic Imaging, have experience in working in or with development stage companies and experience in the capital requirements and funding of such enterprises and have an ability to read and interpret financial statements at a minimum.  There are no limitations on persons that may be suggested as potential directors.

Committees of the Board of Directors

The board of directors of Diagnostic Imaging has no committees.  In the future, it may establish audit, nomination and compensation committees as required. Diagnostic Imaging does not believe any committees are currently required.

Independence of Directors

Our common stock is not currently traded in any public market. Therefore, the company is not required to have independent members of the board of directors.  Neither the Over-the-Counter nor Pink Sheets requires independent persons as directors of companies traded thereon.  Mr. Jagodnik is not an independent director, as he is an employee of the company.

Limitation on Directors’ Liabilities

The bylaws of Diagnostic Imaging provide for full indemnification of its directors and officers under Nevada law.  Nevada law provides that a corporation may indemnify any person who is a party to a suit or action or threatened to be made a party to a suit or action, unless the action is by the corporation or is a derivative action on behalf of the corporation when the suit or action is based on his actions on behalf of the corporation or is based on his actions taken at the request of the corporation, and the actions were taken in good faith for the best interests of the corporation.  Indemnification will include expenses, attorney fees, judgments, fines and settlement amounts.  Where a director or officer is successful on the merits of any suit or action brought against him by reason of his actions for or on behalf of the corporation, he shall be fully indemnified.  Diagnostic Imaging may advance expenses in connection with a suit or action agains t its directors and officers if approved by the stockholders or directors who are not part of the action.  Diagnostic Imaging may obtain insurance for any of the indemnification obligations or may provide other financial arrangements such as establishment of a trust fund or program of self insurance.

COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

Section 16(a) of the Exchange Act requires the Company's directors and executive officers, and persons who own more than 10% of the outstanding shares of the Company's Common Stock, to file initial reports of beneficial ownership and reports of changes in beneficial ownership of shares of Common Stock with the Commission. Such persons are required by Commission regulations to furnish the Company with copies of all Section 16(a) forms they file.

40

Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to the Company during the year ended December 31, 2008, and upon a review of Forms 5 and amendments thereto furnished to the Company with respect to the year ended December 31, 2008, or upon written representations received by the Company from certain reporting persons that no Forms 5 were required for those persons, to its knowledge all the Section 16(a) filing requirements applicable to such persons with respect to fiscal year ended December 31, 2008 were complied with.

AUDIT COMMITTEE AND FINANCIAL EXPERT

We are not required to have and we do not have an Audit Committee. The Company's directors perform some of the same functions of an Audit Committee, such as; recommending a firm of independent certified public accountants to audit the financial statements; reviewing the auditors' independence, the financial statements and their audit report; and reviewing management's administration of the system of internal accounting controls. The Company does not currently have a written audit committee charter or similar document.

We have no audit committee financial expert. Our directors have financial statement preparation and interpretation ability obtained over the years from past business experience and education. We believe the cost related to retaining a financial expert at this time is prohibitive. Further, because of the nature of our current limited operations, we believe the services of a financial expert are not warranted.

CODE OF ETHICS

A code of ethics relates to written standards that are reasonably designed to deter wrongdoing and to promote:

1)

Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships.

2)

Full, fair, accurate, timely and understandable disclosure in reports and documents that are filed with, or submitted to the Securities and Exchange Commission and in other public communications made by the Company.

3)

Compliance with applicable government laws, rules and regulations.

4)

The prompt internal reporting of violations of the code to an appropriate person or persons identified in the code; and,

5)

Accountability for adherence to the code.

We have not adopted a formal code of ethics statement. The board of directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons who are also the officers and directors and many of the persons employed by the Company are independent contractors, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines.

41

SHAREHOLDER-DIRECTOR COMMUNICATION

We have neither a nominating committee for persons to be proposed as directors for election to the board of directors nor a formal method of communicating nominees from shareholders. We do not have any restrictions on shareholder nominations under our certificate of incorporation or by-laws. The only restrictions are those applicable generally under Nevada Corporate Law and the federal proxy rules. Currently the board of directors decides on nominees, on the recommendation of one or more members of the board. None of the members of the board of directors are "independent." The board of directors will consider suggestions from individual shareholders, subject to evaluation of the person's merits. Stockholders may communicate nominee suggestions directly to any of the board members, accompanied by biographical details and a statement of support for the nominees. The suggested nominee must also provide a statement of consent to being considered for nomination. A lthough there are no formal criteria for nominees, the board of directors believes that persons should be actively engaged in business endeavors, have a financial background, and be familiar with acquisition strategies and money management.

Because the management and directors of the Company are the same persons, the board of directors has determined not to adopt a formal methodology for communications from shareholders on the belief that any communication would be brought to the boards' attention by virtue of the co-extensive employment.

The board of directors does not have a formal policy of attendance of directors at the annual meeting. It does encourage such attendance. The Company had an annual meeting in June 2007 and all of the Company directors were in attendance.

ITEM 11. EXECUTIVE COMPENSATION

The following table reflects compensation paid to our officers and directors for the fiscal year ended December 31, 2008.

							LONG TERM COMPENSATION
							AWARDS
		ANNUAL COMPENSATION								PAYOUTS
							RESTRICTED		SECURITIES
							STOCK		UNDERLYING	LTIP	ALL OTHER
NAME AND	YEAR	SALARY		BONUS		OTHER	AWARD		OPTIONS	PAYOUTS	COMPENSATION
PRINCIPAL POSITION	(1)	($)		($)		($)	($)		SARS(#)	($)	($)
Richard Jagodnik,	2008	$	0	$	0		$	0			$0
President & Director	2007	$	0	$	0		$	0			$0
	2006	$	0	$	0		$	0			$0

(1)

 For the fiscal years ended December 31, 2008, 2007 and 2006.

We have not paid any cash compensation or other benefits to our executive officer since our inception, except for the 7,000,000 shares of our common stock which were issued to Mr. Jagodnik in 2005 for management services provided. Until we have sufficient capital or revenues, Mr. Jagodnik will not be provided cash remuneration. At such time as we are able to provide a regular salary, it is our intention that Mr. Jagodnik will become employed pursuant to an executive employment agreement, at an annual salary to be determined based on his then level of time devoted to Diagnostic Imaging and the scope of his responsibilities. Until we enter into an employment agreement, we may use shares of common stock to compensate Mr. Jagodnik. In addition, we may use common stock to compensate others for services to Diagnostic Imaging.

No persons make over $100,000 per year.  

42

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth, as of March 27, 2009, the name and shareholdings of each person who owns of record, or was known by us to own beneficially, 5% or more of the shares of the common stock currently issued and outstanding; the name and shareholdings, including options to acquire the common stock, of each director; and the shareholdings of all executive officers and directors as a group.  

Name of Beneficial Owner	Shares Beneficially Owned (1)	Percent of Class (2)
Richard Jagodnik (3)	7,000,000	53.2%
All directors and executive officers as a group (one person)	7,000,000	53.2%

____________________________________

(1)

Unless otherwise noted, we believe that all persons named in the table have sole voting and investment power with respect to all common shares beneficially owned by them, subject to community property laws, where applicable.

(2)

There are 9,946,647 shares of common stock issued and outstanding as at December 31, 2008.  Each person beneficially owns a percentage of our outstanding common shares which such person has the right to vote or investment power with respect to securities.  

(3)

Mr. Richard Jagodnik’s business address is 21 Malta Dollard des-Ormeaux, Québec, Canada  H9B 2E6.  Mr. Jagodnik received his 7,000,000 shares for management services rendered to the company.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

During 2005, we issued 7,000,000 shares of our common stock to Mr. Richard Jagodnik, our sole officer and director for management services. These shares were valued at $7,000 based on a par value of $0.001 per share. During 2008, Richard Jagodnik loaned the Company $34,407.  During 2007, Richard Jagodnik loaned the Company $31,800.  The note is non-interest bearing and payable on demand.  The balance as of December 31, 2008 is $66,207.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

The company paid audit and financial statement review fees totaling $18,320 and $18,191 for the fiscal years ended December 31, 2008 and 2007, respectively, to Robnett & Company LP, our prior independent accountants.  We paid $12,000 to our new auditors M&K CPAs, PLLC for the combined audit of the years ended December 31, 2008 and 2007 respectively.  

Audit-Related Fees

None

Tax Fees

None

All Other Fees

None

43

Audit committee policies & procedures

The company does not currently have a standing audit committee. The above services were approved by the company’s Board of Directors.

ITEM 15. EXHIBITS

a.  Exhibits

Exhibit Number

Name of Exhibit

31.1

Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002. (1)

31.2

Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002. (1)

32.1

Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 United States Code Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002. (1)

______________________________________________________

(1)

Filed herewith

44

SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DIAGNOSTIC IMAGING INTERNATIONAL CORP.
By:	/s/ Richard Jagodnik
	Richard Jagodnik
	President
Date:	May 13, 2009

Pursuant to the requirements with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Capacities	Date
/s/ Richard Jagodnik	President (Principal Executive Officer, Principal Financial	May 13, 2009
Richard Jagodnik	Officer and Principal Accounting Officer) and Director

45

EX-31

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES OXLEY-ACT OF 2002

I, Richard Jagodnik, Chief Executive Officer of Diagnostic Imaging International Corp., certify that:

1.

I have reviewed this report on Form 10-K of Diagnostic Imaging International Corp.

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 13, 2009	/s/ Richard Jagodnik
	Richard Jagodnik
	Chief Executive Officer

EX-31

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES OXLEY-ACT OF 2002

I, Richard Jagodnik, Chief Financial Officer of Diagnostic Imaging International Corp. certify that:

1.

I have reviewed this report on Form 10-K of Diagnostic Imaging International Corp.

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 13, 2009	/s/ Richard Jagodnik
	Richard Jagodnik
	Chief Financial Officer

EX-32

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Diagnostic Imaging International Corp. (the “Company”) on 10-K for the year ended December 31, 2008 as filed with the Securities and Exchange Commission (the “Report”), I, Richard Jagodnik, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 13, 2009	/s/ Richard Jagodnik
	Richard Jagodnik
	Chief Executive Officer, Chief Financial Officer

CORRESP

Diagnostic Imaging International Corp.

848 N. Rainbow Blvd. #2494

Las Vegas, Nevada 89107

May 14, 2009

Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Attn: Ethan Horowitz

Re:

Diagnostic Imaging International Corp.
Form 10-K/A for Fiscal Year Ended
December 31, 2008

Filed April 29, 2009

File No. 333-136436

Dear Mr. Horowitz:

Reference is made to the letter from the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission, dated May 4, 2009, setting forth comments to the Form 10-K/A (the “10-K”) filed by Diagnostic Imaging International Corp. (the “Company”) on April 29, 2009. Set forth below are the Staff’s comments, indicated in bold, and the Company’s responses.

Form 10-K/A for Fiscal Year Ended December 31, 2008

Item 8 – Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm, F-1

1.

We note that your independent accountant is relying on the work performed by their predecessor, Robnett & Company, for the period from March 14, 2002 (inception) through December 31, 2006.  Please advise your independent accountant to revise their report to state the date of the report issued by their predecessor.  Refer to AU 508.

Response:  Our independent accountant has revised its report accordingly.

2.

In connection with the comment above, please revise to provide the audit report issued by Robnett & Company that provides assurance on your statements of operations, changes in stockholders’ equity (deficit), and cash flows for the period March 14, 2002 (inception) through December 31, 2006.  If you are unable to provide this report from you predecessor accountant, you should have a firm that is registered with the PCAOB re-audit this period and amend your filing to include an appropriate audit report for the referenced period.

Response:  We have revised the 10-K to provided the requisite reports/consents from Robnett.

Should you have any questions regarding the foregoing or require any additional information, please do not hesitate to contact the undersigned at (603) 727-8613.

Sincerely,

/s/ Richard Jagodnik

Richard Jagodnik,

President